HomeMRKR • NASDAQ
Marker Therapeutics Inc
$4.30
Mar 28, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$4.46
Day range
$4.15 - $4.55
Year range
$0.67 - $9.68
Market cap
38.18M USD
Avg Volume
19.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Sep 2023Y/Y change
Revenue
257.61K-74.23%
Operating expense
1.41M-56.32%
Net income
-2.98M56.91%
Net profit margin
-1.16K-67.22%
Earnings per share
EBITDA
-2.50M50.01%
Effective tax rate
Total assets
Total liabilities
(USD)Sep 2023Y/Y change
Cash and short-term investments
17.47M-3.33%
Total assets
19.49M-52.60%
Total liabilities
2.78M-84.99%
Total equity
16.71M
Shares outstanding
8.89M
Price to book
2.37
Return on assets
-38.61%
Return on capital
-44.77%
Net change in cash
(USD)Sep 2023Y/Y change
Net income
-2.98M56.91%
Cash from operations
-1.13M85.25%
Cash from investing
0.00100.00%
Cash from financing
479.27K
Net change in cash
-648.19K91.63%
Free cash flow
-145.57K97.37%
About
Founded
1992
Employees
8
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu